HIMS
-
More healthcare startups go public through SPACs — but will they succeed?
More healthcare startups are choosing to go public through mergers with special-purpose acquisition companies— publicly-traded shell companies created with the purpose of taking a private company public. But as the number of SPACs searching for targets increases, will the SPAC bubble burst?
-
After $1.6B blank-check deal, Hims & Hers plots expansion into more conditions
The three-year-old digital health startup began trading on the New York Stock Exchange on Thursday. It merged with a subsidiary of Oaktree Capital Management in a deal that valued the company at $1.6 billion.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
Men’s wellness startup Hims rolls out telepsychiatry
Hims, a men’s wellness startup that offers hair loss treatments, mail order supplements and other wellness tools, is expanding into the mental health space. The company is offering virtual psychiatry consultations and plans to offer one-on-one therapy in the future.
-
Hospitals, Startups, Health Tech
Ochsner Health System partners with direct-to-consumer health startup
Oschner will partner with mail-order health company Hims & Hers to screen patients for blood pressure or diabetes.
-
This is the startup enabling fast-growing mail-order prescription drug brands
Behind companies like Hims, Nurx and Lemonaid sits Truepill’s technology, which handles the logistics, shipping and pharmacy fulfillment necessary to run the direct-to-consumer businesses.